Agilon Health (AGL)
NYSE:AGL
Want to see AGL full AI Analyst Report?
AGL Stock Chart & Stats
$26.88
$0.02(1.16%)
At close: 4:00 PM EST
$26.88
$0.02(1.16%)
Day’s Range― - ―
52-Week Range$7.48 - $140.98
Previous CloseN/A
Volume1.09M
Average Volume (3M)258.94K
Market Cap
$446.37M
Enterprise Value$309.47M
Total Cash (Recent Filing)$285.14M
Total Debt (Recent Filing)$36.81M
Price to Earnings (P/E)―
Beta1.63
Next Earnings
May 06, 2026EPS Estimate
1.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-11.50
Shares Outstanding16,605,993
10 Day Avg. Volume415,223
30 Day Avg. Volume258,943
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)2.25
Price to Sales (P/S)0.05
P/FCF Ratio-2.40
Enterprise Value/Market Cap0.69
Enterprise Value/Revenue0.05
Enterprise Value/Gross Profit-1.77
Enterprise Value/Ebitda-0.84
Forecast
1Y Price Target
$17.32Price Target Upside-35.57% Downside
Rating ConsensusHold
Number of Analyst Covering12
EPS Forecast (FY)-5.72
Revenue Forecast (FY)$5.50B
Bulls Say, Bears Say
Bulls Say
Liquidity And Cash RunwayAnalyst points to an extended credit facility and an expected cash balance that should provide runway while profitability recovers amid medical cost and regulatory uncertainty.
Medicare Advantage RatesAnalyst notes stronger-than-expected Medicare Advantage rates and smaller chart review impacts could allow plans to adjust benefits, recapture margin, and improve earnings potential.
Prescription Drug Benefit ExposureAnalyst highlights reduced exposure to the prescription drug benefit as a way to lower margin risk and support more stable profitability.
Bears Say
Guidance Visibility And Profitability MissesAnalyst flags that adjusted EBITDA results fell short of expectations and ongoing difficulties in forecasting costs create uncertainty around guidance and the company's cash position.
Membership Exits And Start-up CostsAnalyst notes planned exits from certain Medicare Advantage contracts and transitions of care lives into other programs could reduce membership and weigh on near-term profitability due to start-up costs.
Rising Medical Costs And Prior-year AdjustmentsAnalyst cautions that a high medical cost trend and potential unfavorable prior-year adjustments could pressure profitability and hinder margin recovery.
Agilon Health News
AGL FAQ
What was Agilon Health’s price range in the past 12 months?
Agilon Health lowest stock price was $7.48 and its highest was $140.97 in the past 12 months.
What is Agilon Health’s market cap?
Agilon Health’s market cap is $446.37M.
When is Agilon Health’s upcoming earnings report date?
Agilon Health’s upcoming earnings report date is May 06, 2026 which is in 20 days.
How were Agilon Health’s earnings last quarter?
Agilon Health released its earnings results on Feb 25, 2026. The company reported -$11.5 earnings per share for the quarter, missing the consensus estimate of -$7.07 by -$4.43.
Is Agilon Health overvalued?
According to Wall Street analysts Agilon Health’s price is currently Overvalued.
Does Agilon Health pay dividends?
Agilon Health pays a Quarterly dividend of $0.45 which represents an annual dividend yield of N/A. See more information on Agilon Health dividends here
What is Agilon Health’s EPS estimate?
Agilon Health’s EPS estimate is 1.03.
How many shares outstanding does Agilon Health have?
Agilon Health has 16,605,993 shares outstanding.
What happened to Agilon Health’s price movement after its last earnings report?
Agilon Health reported an EPS of -$11.5 in its last earnings report, missing expectations of -$7.07. Following the earnings report the stock price went up 18.92%.
Which hedge fund is a major shareholder of Agilon Health?
Currently, no hedge funds are holding shares in AGL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Agilon Health Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$17.32 (-35.57% Downside)
$17.32 (-35.57% Downside)
Blogger Sentiment
Bearish
AGL Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 7.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $50.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 3.0%
Last 30 Days ▲ 0.5%
Last 30 Days ▲ 0.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-83.80%
12-Months-Change
Fundamentals
Return on Equity
-116.65%
Trailing 12-Months
Asset Growth
-26.68%
Trailing 12-Months
Company Description
Agilon Health
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.
AGL Company Deck
AGL Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call communicated a clear, quantified plan for a material financial turnaround in 2026 — including specific revenue, medical margin and adjusted EBITDA targets — supported by strengthened data/analytics, scaled clinical pathways (CHF adoption >90%), quality improvement (composite ~4.2 stars) and $35M of operating cost reductions. However, significant 2025 losses (FY adjusted EBITDA -$296M), elevated and volatile medical cost trends (2025 ~6.5%, 2026 assumed gross 7.5%/net 7.0%), membership contraction from contract exits (≈50k MA members), and regulatory uncertainty around CMS’ rate notice present meaningful near-term risks. On balance, the call presented balanced progress and material challenges: management provided credible levers and quantified guidance for improvement, but execution and external factors (cost trends, CMS rates, claims visibility) are non‑trivial risks to achieving the stated goals.View all AGL earnings summariesAGL Stock 12 Month Forecast
Average Price Target
$17.32
▼(-35.57% Downside)
Technical Analysis
AMN Healthcare Services
―
Cross Country Healthcare
―
InnovAge Holding
―
P3 Health Partners
―
biote
―
Ownership Overview
Currently, No data available
---